Loan Agreements in the Biotechnology Industry

1,163 Contracts & Agreements

Browse by Company

89bio, Inc. (5 contracts)
AbbVie Inc. (7)
ABEONA THERAPEUTICS INC. (2)
ACCELERON PHARMA INC (1)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (1)
Adamas Pharmaceuticals Inc (3)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (6)
ADMA BIOLOGICS, INC. (8)
AGENUS INC (1)
AgeX Therapeutics, Inc. (3)
Akebia Therapeutics, Inc. (5)
Akero Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (2)
Aldeyra Therapeutics, Inc. (9)
Alexion Pharmaceuticals (2)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (2)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (2)
Altimmune, Inc. (1)
ALX ONCOLOGY HOLDINGS INC (4)
AMARIN CORP PLC (1)
Amgen Inc. (2)
ANAPTYSBIO INC (3)
ANAVEX LIFE SCIENCES CORP. (5)
Apellis Pharmaceuticals, Inc. (1)
APPLIED GENETIC TECHNOLOGIES CORP (2)
Aptinyx Inc. (1)
AquaBounty Technologies, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
ARCA biopharma, Inc. (7)
Arcturus Therapeutics Holdings Inc. (4)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (7)
Arsanis, Inc. (9)
Athenex, Inc. (1)
aTYR PHARMA INC (5)
AVEO PHARMACEUTICALS INC (9)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (1)
AVROBIO, Inc. (2)
Axcella Health Inc. (5)
Axovant Sciences Ltd. (4)
AZIYO BIOLOGICS, INC. (6)
AzurRx BioPharma, Inc. (1)
BAKKEN RESOURCES INC (1)
BeiGene, Ltd. (3)
BELLICUM PHARMACEUTICALS, INC (7)
BICYCLE THERAPEUTICS Ltd (3)
BIOCEPT INC (6)
BioLife4D Corp (2)
BIOMARIN PHARMACEUTICAL INC (5)
BioRestorative Therapies, Inc. (2)
BIOVIE INC. (2)
BioXcel Therapeutics, Inc. (1)
Blueprint Medicines Corp (2)
BridgeBio Pharma, Inc. (8)
CALADRIUS BIOSCIENCES, INC. (5)
CANCER GENETICS, INC (8)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (12)
Capstone Therapeutics Corp. (4)
CareDx, Inc. (4)
CASI Pharmaceuticals, Inc. (2)
CASTLE BIOSCIENCES INC (8)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (3)
Celcuity Inc. (2)
Celldex Therapeutics, Inc. (4)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (4)
Celsion CORP (6)
Century Therapeutics, Inc. (2)
Chardan Healthcare Acquisition Corp. (1)
Chelsea Worldwide Inc. (7)
ChemoCentryx, Inc. (8)
CHIMERIX INC (2)
Cidara Therapeutics, Inc. (7)
CLEVELAND BIOLABS INC (5)
Coherus BioSciences, Inc. (4)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (3)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (2)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
CTD HOLDINGS INC (19)
CTI BIOPHARMA CORP (8)
Cue Biopharma, Inc. (1)
Cyclacel Pharmaceuticals, Inc. (1)
Cytokinetics, Incorporated (8)
CytomX Therapeutics, Inc. (3)
CYTORI THERAPEUTICS, INC. (21)
CYTRX CORP (3)
DelMar Pharmaceuticals, Inc. (1)
Dermavant Sciences Ltd (1)
Dermira, Inc. (2)
Dicerna Pharmaceuticals Inc (2)
DYADIC INTERNATIONAL INC (1)
DYNAVAX TECHNOLOGIES CORP (5)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (5)
Eidos Therapeutics, Inc. (2)
Eiger BioPharmaceuticals, Inc. (9)
Elevation Oncology, Inc. (1)
Emerald Bioscience, Inc. (1)
Emergent BioSolutions Inc. (10)
Enochian Biosciences Inc (1)
Epizyme, Inc. (2)
Equillium, Inc. (4)
Esperion Therapeutics, Inc. (4)
Evelo Biosciences, Inc. (9)
EXACT SCIENCES CORP (4)
Exelixis (6)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (5)
FENNEC PHARMACEUTICALS INC. (4)
Finch Therapeutics Group, Inc. (1)
Foghorn Therapeutics Inc. (2)
Fortress Biotech, Inc. (1)
Frequency Therapeutics, Inc. (1)
Fusion Pharmaceuticals Inc. (3)
G1 Therapeutics, Inc. (5)
GALECTIN THERAPEUTICS INC (1)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (1)
GENOCEA BIOSCIENCES, INC. (8)
GERON CORP (4)
Gilead Sciences (1)
Global Blood Therapeutics, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (1)
GX Acquisition Corp. (4)
HALOZYME THERAPEUTICS INC (8)
HCW Biologics Inc. (1)
HEAT BIOLOGICS, INC. (10)
HilleVax, Inc. (3)
HISTOGENICS CORP (1)
Homology Medicines, Inc. (9)
HUMANIGEN, INC (18)
IMMUCELL CORP (8)
IMMUNE PHARMACEUTICALS INC (6)
Immune Therapeutics, Inc. (2)
IMPEL NEUROPHARMA INC (5)
INFINITY PHARMACEUTICALS, INC. (2)
Inhibikase Therapeutics, Inc. (4)
Inhibrx, Inc. (9)
Inmune Bio, Inc. (1)
Inozyme Pharma, Inc. (1)
INSMED Inc (6)
Instil Bio, Inc. (2)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (6)
Isoray, Inc. (3)
KalVista Pharmaceuticals, Inc. (5)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (3)
Kura Oncology, Inc. (7)
LEXICON PHARMACEUTICALS, INC. (12)
Ligand Pharmaceuticals Incorporated (13)
Locust Walk Acquisition Corp. (4)
LogicBio Therapeutics, Inc. (4)
MADRIGAL PHARMACEUTICALS, INC. (14)
MATEON THERAPEUTICS INC (3)
MEDICINOVA INC (1)
Medovex Corp. (2)
MERRIMACK PHARMACEUTICALS INC (8)
Mersana Therapeutics, Inc. (9)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (2)
MiMedx Group, Inc. (1)
Minerva Neurosciences, Inc. (5)
MIRAGEN THERAPEUTICS, INC. (4)
Molecular Templates, Inc. (4)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (15)
NEUROBIOLOGICAL TECHNOLOGIES INC (2)
NEWLINK GENETICS CORP (1)
NORTHWEST BIOTHERAPEUTICS INC (22)
NTN BUZZTIME INC (10)
Olema Pharmaceuticals, Inc. (1)
Olivia Ventures, Inc. (4)
Omega Therapeutics, Inc. (3)
OncoCyte Corp (3)
Oncorus, Inc. (1)
Ophthotech Corp. (1)
Opko Health, Inc. (3)
ORAGENICS INC (4)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (21)
PALATIN TECHNOLOGIES INC (1)
PhaseBio Pharmaceuticals Inc (3)
PIERIS PHARMACEUTICALS, INC. (3)
POLARITYTE, INC. (1)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (6)
PRECISION BIOSCIENCES INC (7)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
PREMIER BIOMEDICAL INC (1)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (1)
Propanc Biopharma, Inc. (1)
PROTEOSTASIS THERAPEUTICS, INC. (4)
PUMA BIOTECHNOLOGY, INC. (8)
Radius Health, Inc. (8)
Regulus Therapeutics Inc. (14)
RenovaCare, Inc. (9)
Replimune Group, Inc. (4)
Rezolute, Inc. (1)
RIGEL PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (3)
Sarepta Therapeutics, Inc. (1)
Savara Inc (13)
Scholar Rock Holding Corp (4)
SELECTA BIOSCIENCES INC (6)
SELLAS Life Sciences Group, Inc. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (3)
Sierra Oncology, Inc. (2)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (1)
SOLENO THERAPEUTICS INC (1)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (5)
Sorrento Therapeutics, Inc. (19)
Spectrum Pharmaceuticals, Inc. (1)
SPHERIX INC (1)
Spring Bank Pharmaceuticals, Inc. (3)
SPRUCE BIOSCIENCES, INC. (3)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (12)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (6)
Syndax Pharmaceuticals Inc (8)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (11)
Taysha Gene Therapies, Inc. (2)
TG THERAPEUTICS, INC. (3)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (1)
Tracon Pharmaceuticals, Inc. (8)
TREVENA INC (6)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (1)
Twist Bioscience Corp (1)
U.S. Stem Cell, Inc. (15)
uniQure N.V. (6)
United Therapeutics Corp (1)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (6)
UroGen Pharma Ltd. (1)
Vaxart, Inc. (2)
VBI Vaccines Inc (4)
Vera Therapeutics, Inc. (2)
VERACYTE, INC. (3)
Verastem, Inc. (7)
Vericel Corp (6)
Viking Therapeutics, Inc. (4)
vTv Therapeutics Inc. (5)
Werewolf Therapeutics, Inc. (3)
WINDTREE THERAPEUTICS INC (20)
XBiotech Inc. (1)
Xenon Pharmaceuticals Inc. (3)
Xilio Therapeutics, Inc. (3)
XOMA Corp (14)
ZAFGEN, INC. (1)
Zai Lab Ltd (1)
ZIOPHARM ONCOLOGY INC (2)

Recent Contracts

Consent and Amendment No. 10 to Term Loan Agreement, dated April 12, 2024, by and among the Company, CRG Servicing LLC, as administrative agent and collateral agent, and the... (T2 Biosystems, Inc., Filed With SEC on April 18, 2024)
Consent and First Amendment to Economic Recovery Loan Program Loan Agreement, dated April 8, 2024, by and between the Company and the Finance Authority of Maine (IMMUCELL CORP, Filed With SEC on April 9, 2024)
Consent and Eighth Amendment to Loan and Security Agreement, by and between Q32 Bio, Inc. and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, dated March... (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
Loan and Security Agreement, by and between the Company, Castle Narnia Real Estate Holding 1, LLC and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, dated... (CASTLE BIOSCIENCES INC, Filed With SEC on March 27, 2024)
Second Amendment to Loan and Security Agreement, dated November 3, 2023, by and among Oxford Finance LLC, Tempest Therapeutics, Inc., Tempest TX, Inc. and Millendo Therapeutics... (Millendo Therapeutics, Inc., Filed With SEC on March 19, 2024)
Second Amended and Restated Revolving Loan Promissory Note, dated March 13, 2024 (AzurRx BioPharma, Inc., Filed With SEC on March 14, 2024)
Agreement for the Provision of a Loan Facility dated January 29, 2024 between the Company and Kreos Capital VII (UK) Limited (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
Fourth Amendment to Loan Agreement dated as of October 31, 2023, by and among the Company, BioPharma Credit PLC, BPCR Limted Partnership, and BioPharma Credit Investments V... (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
Fifth Amendment to Loan and Security Agreement, dated March 6, 2024, with Oxford Finance, LLC and the lenders listed therein (LEXICON PHARMACEUTICALS, INC., Filed With SEC on March 11, 2024)
Loan Agreement dated December 15, 2023, between XRL 1 LLC, the lenders from time to time party thereto and Blue Owl Capital Corporation (XOMA Corp, Filed With SEC on March 8, 2024)
Second Amendment to Loan and Security Agreement, dated March 1, 2024, by and between the Registrant and Oxford Finance LLC and First-Citizens Bank & Trust Company (SUNESIS PHARMACEUTICALS INC, Filed With SEC on March 7, 2024)
Ten Amendment to Loan and Security Agreement, dated June 28, 2023, by and among Plus Therapeutics, Inc., Oxford Finance, LLC and lenders listed thereof (CYTORI THERAPEUTICS, INC., Filed With SEC on March 5, 2024)
Loan Agreement, dated November 10, 2023, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (NORTHWEST BIOTHERAPEUTICS INC, Filed With SEC on March 5, 2024)
Loan Agreement, dated March 2, 2023, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (NORTHWEST BIOTHERAPEUTICS INC, Filed With SEC on March 5, 2024)
First Amendment to Loan and Security Agreement, dated November 21, 2023, by and between the Registrant and Silicon Valley Bank (CHIMERIX INC, Filed With SEC on February 29, 2024)
Second Amendment to Loan and Security Agreement, dated as of December 22, 2023, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc (Replimune Group, Inc., Filed With SEC on February 8, 2024)
Unofficial English Translation of Working Capital Loan Agreement, dated as of February (Zai Lab Ltd, Filed With SEC on February 8, 2024)
Consent, Partial Release and Third Amendment to Loan Agreement dated as of February 5, 2024 among Coherus BioSciences, Inc., Biopharma Credit PLC, BPCR Limited Partnership and... (Coherus BioSciences, Inc., Filed With SEC on February 5, 2024)
Form of Business Loan and Security Agreement dated January 24, 2024 (ADiTx Therapeutics, Inc., Filed With SEC on January 30, 2024)
Second Amended and Restated Loan Agreement, among Celularity Inc., Celularity LLC and Resorts World Inc Pte Ltd dated as of January 12, 2024 (GX Acquisition Corp., Filed With SEC on January 17, 2024)
Supplement to the Loan and Security Agreement, by and among Abeona Therapeutics, Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as... (ABEONA THERAPEUTICS INC., Filed With SEC on January 8, 2024)
Loan and Security Agreement, by and among Abeona Therapeutics, Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as Agent, and Avenue... (ABEONA THERAPEUTICS INC., Filed With SEC on January 8, 2024)
First Amendment to Loan and Security Agreement, dated as of January 4, 2024, among Verastem, Inc., as borrower, Oxford Finance LLC, as collateral agent and a lender, and the other... (Verastem, Inc., Filed With SEC on January 8, 2024)
Loan Extension Agreement, dated as of January 1, 2024, by and between the Company and Aharon Lukach (Orgenesis Inc., Filed With SEC on January 5, 2024)
Loan Extension Agreement, dated as of January 1, 2024, by and between the Company and Yehuda Nir (Orgenesis Inc., Filed With SEC on January 5, 2024)
Convertible Loan Agreement (XBiotech Inc., Filed With SEC on January 4, 2024)
Fourth Amendment to Loan and Security Agreement, dated December 29, 2023, with Oxford Finance, LLC and the lenders listed therein (LEXICON PHARMACEUTICALS, INC., Filed With SEC on December 29, 2023)
Third Amendment to Loan and Security Agreement, dated as of December 22, 2023, among Oxford Finance LLC, as collateral agent, the lenders party thereto, ALX Oncology Inc., as... (ALX ONCOLOGY HOLDINGS INC, Filed With SEC on December 26, 2023)
Seventh Amendment to Loan and Security Agreement, dated November 2, 2023, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Sixth Amendment to Loan and Security Agreement, dated July12, 2023, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Fifth Amendment to Loan and Security Agreement, dated April 26, 2023, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Fourth Amendment to Loan and Security Agreement, dated December 21, 2022, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Third Amendment to Loan and Security Agreement, dated August 10, 2022, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Second Amendment to Loan and Security Agreement, dated June 30, 2022, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
First Amendment to Loan and Security Agreement, dated December 30, 2021, by and between Q32 Bio Inc. and Silicon Valley Bank (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Loan and Security Agreement, dated as of December 11, 2020, by and between Q32 Bio Inc. and Silicon Valley Bank, as amended (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Loan and Guaranty Agreement, dated as of December 8, 2023, by and among the Loan Parties, the Lenders and the JGB Agent (Tonix Pharmaceuticals Holding Corp., Filed With SEC on December 8, 2023)
Loan and Securities Exchange Agreement effective as of November 27, 2023 between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on December 1, 2023)
Amendment No. 9 to Term Loan Agreement, dated October 18, 2023, between T2 Biosystems, Inc. and CRG Servicing LLC (T2 Biosystems, Inc., Filed With SEC on November 15, 2023)
Loan and Security Agreement, dated November 13, 2023 by and among the Company (Taysha Gene Therapies, Inc., Filed With SEC on November 14, 2023)